Skip to content
Swanley Therapy Centre

Swanley Therapy Centre

Swanley Unit for Multiple Sclerosis [S.U.M.S.]

donate

Menu

  • Home
  • About Us
    • Contact Us
    • Centre Manager Vacancy
    • The Team
    • The Volunteer Team
    • Gallery
  • Services
    • Oxygen Therapy
    • Chiropody
    • Pilates
    • Bowen Therapy
    • MS Support
  • Fundraising
    • 100 Club
    • Donations
    • Fundraising Events
    • Legacies and Wills
    • Supporters
    • Volunteering
  • News
    • Blog
    • Testimonials
    • MS News
    • Newsletter
  • What’s On
  • How to Find Us
  • facebook
  • twitter
  • instagram
Search

Posts with the Clinical Trial tag

Latest MS News, MS News

Effect of vitamin D supplements on MS activity

Written by Ellen on February 27th, 2020.

People with MS are often advised to take high doses of vitamin D, but there’s been very little research to assess what effect this might have. Two recent clinical trials (CHOLINE and SOLAR) investigated the effect of vitamin D supplements in people with relapsing remitting MS already taking a disease modifying drug.

Continue Reading Effect of vitamin D supplements on MS activity
General, Latest MS News, MS News

The Evidence for Oxygen awarded the 2019 Nobel prize

Written by Ellen on January 29th, 2020November 26th, 2020.

We wanted to draw attention to an interesting article published in the HBOTT Dec 2019 Newsletter.

Continue Reading The Evidence for Oxygen awarded the 2019 Nobel prize
Latest MS News, MS News

Tysabri: reducing the risk of PML with extended interval dosing

Written by Ellen on December 12th, 2019February 27th, 2020.

Tysabri (natalizumab) is very effective for people with highly active relapsing remitting MS but it carries the risk of developing a rare but very serious brain infection called progressive multifocal leukoencephalopathy (PML).

Continue Reading Tysabri: reducing the risk of PML with extended interval dosing
Latest MS News, MS News

Sativex approved by NICE

Written by Ellen on November 20th, 2019February 27th, 2020.

Sativex, a cannabis based drug for MS related spasticity, has been approved by NICE as a cost effective treatment for the NHS in England.

Continue Reading Sativex approved by NICE
Latest MS News, MS News

Siponimod recommended for secondary progressive MS by EMA

Written by Ellen on November 20th, 2019February 27th, 2020.

The European Medicines Agency (EMA) has recommended that a licence should be granted for siponimod (Mayzent) for the treatment of active secondary progressive MS (SPMS).

Continue Reading Siponimod recommended for secondary progressive MS by EMA

Swanley Therapy Centre [HDOT]

Unit 8
Park Road Industrial Estate
Swanley
Kent BR8 8AH

01322 663042

opening times

swanley-oxygen-treatment-centre

Tuesday: 9am-2pm
Wednesday: 9am-2pm; 7pm-8:30pm
Thursday: 9am-1pm
Saturday: 9am-2pm

Disabled Access

Registered Charity No: 801112
Registered Company No: 2345991

Follow us on:

Visitors to date:

94229
  • Site Map
  • Privacy Policy
  • How to Find Us
  • Contact Us
© Copyright 2021 Swanley Therapy Centre . All Rights Reserved.